BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37581775)

  • 1. The impact of primary tumor resection for asymptomatic colorectal cancer patients with unresectable metastases: a systematic review and meta-analysis.
    Li S; Ji L; Huang J; Wang Y; Liu P; Zhang W; Lou Z
    Int J Colorectal Dis; 2023 Aug; 38(1):214. PubMed ID: 37581775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary Tumor Resection Plus Chemotherapy Versus Chemotherapy Alone for Colorectal Cancer Patients With Asymptomatic, Synchronous Unresectable Metastases (JCOG1007; iPACS): A Randomized Clinical Trial.
    Kanemitsu Y; Shitara K; Mizusawa J; Hamaguchi T; Shida D; Komori K; Ikeda S; Ojima H; Ike H; Shiomi A; Watanabe J; Takii Y; Yamaguchi T; Katsumata K; Ito M; Okuda J; Hyakudomi R; Shimada Y; Katayama H; Fukuda H;
    J Clin Oncol; 2021 Apr; 39(10):1098-1107. PubMed ID: 33560877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-front systemic chemotherapy is a feasible option compared to primary tumor resection followed by chemotherapy for colorectal cancer with unresectable synchronous metastases.
    Niitsu H; Hinoi T; Shimomura M; Egi H; Hattori M; Ishizaki Y; Adachi T; Saito Y; Miguchi M; Sawada H; Kochi M; Mukai S; Ohdan H
    World J Surg Oncol; 2015 Apr; 13():162. PubMed ID: 25908502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative chemotherapy prior to primary tumour resection for asymptomatic synchronous unresectable colorectal liver-limited metastases: The RECUT multicenter randomised controlled trial.
    Lin Q; Ding K; Zhao R; Wang H; Wei Y; Ren L; Ye Q; Cui Y; He G; Tang W; Feng Q; Zhu D; Chang W; Wang X; Liang L; Zhou G; Liang F; Ye F; Wang J; Fan J; Xu J
    Eur J Cancer; 2023 Sep; 191():112961. PubMed ID: 37473466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of primary tumor resection in colorectal cancer patients with synchronous unresectable metastasis.
    Kim MS; Chung M; Ahn JB; Kim CW; Cho MS; Shin SJ; Baek SJ; Hur H; Min BS; Baik SH; Kim NK
    J Surg Oncol; 2014 Aug; 110(2):214-21. PubMed ID: 24668581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of primary tumor resection in colorectal cancer patients with asymptomatic, synchronous unresectable metastasis: Study protocol for a randomized controlled trial.
    Kim CW; Baek JH; Choi GS; Yu CS; Kang SB; Park WC; Lee BH; Kim HR; Oh JH; Kim JH; Jeong SY; Ahn JB; Baik SH
    Trials; 2016 Jan; 17():34. PubMed ID: 26782254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Primary Tumor Resection in Colorectal Cancer Patients with Asymptomatic, Synchronous, Unresectable Metastasis: A Multicenter Randomized Controlled Trial.
    Park EJ; Baek JH; Choi GS; Park WC; Yu CS; Kang SB; Min BS; Kim JH; Kim HR; Lee BH; Oh JH; Jeong SY; Jung M; Ahn JB; Baik SH
    Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32824392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary tumor resection in patients with unresectable colorectal cancer with synchronous metastases could improve the activity of poly-chemotherapy: A trial-level meta-analysis.
    Colloca GA; Venturino A; Guarneri D
    Surg Oncol; 2022 Sep; 44():101820. PubMed ID: 35932621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sixty-Day Mortality of Patients With Metastatic Colorectal Cancer Randomized to Systemic Treatment vs Primary Tumor Resection Followed by Systemic Treatment: The CAIRO4 Phase 3 Randomized Clinical Trial.
    van der Kruijssen DEW; Elias SG; Vink GR; van Rooijen KL; 't Lam-Boer J; Mol L; Punt CJA; de Wilt JHW; Koopman M;
    JAMA Surg; 2021 Dec; 156(12):1093-1101. PubMed ID: 34613339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival outcomes following primary tumor resection for patients with incurable metastatic colorectal carcinoma: Experience from a single institution.
    Lau JW; Chang HS; Lee KY; Gwee YX; Lee WQ; Chong CS
    J Dig Dis; 2018 Sep; 19(9):550-560. PubMed ID: 30117288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The outcome of primary tumor resection in the unresectable stage IV colorectal cancer patients who received the bevacizumab-containing chemotherapy.
    Yeom SS; Lee SY; Kwak HD; Kim CH; Kim YJ; Kim HR
    Medicine (Baltimore); 2020 Feb; 99(7):e19258. PubMed ID: 32049866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary Tumour Resection Could Improve the Survival of Unresectable Metastatic Colorectal Cancer Patients Receiving Bevacizumab-Containing Chemotherapy.
    Wang Z; Liang L; Yu Y; Wang Y; Zhuang R; Chen Y; Cui Y; Zhou Y; Liu T
    Cell Physiol Biochem; 2016; 39(3):1239-46. PubMed ID: 27595400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Analysis of Relationship Between RAS Mutations and Prognosis of Primary Tumour Resection for Metastatic Colorectal Cancer Patients.
    Liang L; Tian J; Yu Y; Wang Z; Peng K; Liu R; Wang Y; Xu X; Li H; Zhuang R; Cui Y; Zhu C; Liu T
    Cell Physiol Biochem; 2018; 50(2):768-782. PubMed ID: 30308491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of primary tumor resection on survival in patients with asymptomatic unresectable metastatic colorectal cancer: a systematic review and meta-analysis.
    Zhang C; Cao C; Liu L; Lv Y; Li J; Lu J; Wang S; Du B; Yang X
    Expert Rev Anticancer Ther; 2023 Jan; 23(1):107-115. PubMed ID: 36397266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of upfront primary tumor resection in asymptomatic patients with unresectable stage IV colorectal cancer: A systematic review and meta-analysis.
    Liang Z; Liu Z; Huang C; Chen X; Zhang Z; Xiang M; Hu W; Wang J; Feng X; Yao X
    Front Surg; 2022; 9():1047373. PubMed ID: 36684350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary Tumor Resection Plus Chemotherapy versus Chemotherapy Alone for Colorectal Cancer Patients with Synchronous Bone Metastasis.
    Li Y; Cheng X; Zhong C; Yuan Y
    Medicina (Kaunas); 2023 Jul; 59(8):. PubMed ID: 37629673
    [No Abstract]   [Full Text] [Related]  

  • 17. Induction Chemotherapy Followed by Primary Tumor Resection Did Not Bring Survival Benefits in Colon Cancer Patients With Asymptomatic Primary Lesion and Synchronous Unresectable Metastases.
    Huang M; Yang Y; Li Q; Wang C; Liang L; Zhu X; Zhang W; Chen Z; Huang D; Li W; Zhang X; Zhao X; Qiu L; Geng Q; Yu N; Du W; Sun S; Sheng X; Li X; Guo W
    Front Oncol; 2022; 12():747124. PubMed ID: 35174078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effectiveness of primary tumor resection versus chemotherapy in patients with asymptomatic unresectable metastatic colorectal cancer: a retrospective cohort study using the target trial emulation framework.
    Wu CC; Su CC; Lee PT; Chen YH; Hsu CW; Su YC
    Am J Cancer Res; 2024; 14(5):2172-2186. PubMed ID: 38859829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary tumor resection in colorectal cancer with unresectable synchronous metastases: A review.
    de Mestier L; Manceau G; Neuzillet C; Bachet JB; Spano JP; Kianmanesh R; Vaillant JC; Bouché O; Hannoun L; Karoui M
    World J Gastrointest Oncol; 2014 Jun; 6(6):156-69. PubMed ID: 24936226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of primary tumor resection in patients with stage IV colorectal cancer with unresectable metastases.
    Urvay S; Eren T; Civelek B; Kilickap S; Yetiysigit T; Ozaslan E
    J BUON; 2020; 25(2):939-944. PubMed ID: 32521889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.